
USFDA29 Jan 2025, 11:20 pm
GRANULES INDIA LTD. Receives EU GMP Certificate for APIs and FDs at Unit V Facility
AI Summary
GRANULES INDIA LTD. has announced that its Unit V facility located at Anakapally, Visakhapatnam, Andhra Pradesh, India has received the EU GMP certificate for Active Pharmaceutical Ingredients (APIs) and Finished Dosages (FDs). The EU authority conducted the audit in November 2024. This facility is responsible for manufacturing APIs and formulations of oncology and non-oncology products. This is a significant update for the members of the exchange.
Key Highlights
- GRANULES INDIA LTD. receives EU GMP certificate for Unit V facility
- Facility located at Anakapally, Visakhapatnam, Andhra Pradesh, India
- Certification for Active Pharmaceutical Ingredients (APIs) and Finished Dosages (FDs)
- EU authority conducted the audit in November 2024
- Facility manufactures APIs & formulations of oncology and non-oncology products